Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

124.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
124.0K
Anorexia Nervosa01:28

Anorexia Nervosa

1.7K
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.7K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

4.4K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Autophagic Cell Death01:18

Autophagic Cell Death

4.9K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Bulimia Nervosa01:30

Bulimia Nervosa

921
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
921

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of Coherent Elastic Neutrino-Nucleus Scattering with COHERENT's Germanium Array.

Physical review letters·2025
Same author

Military concerns for chronic pain stimulator devices.

BMJ military health·2023
Same author

First Direct Detection Constraints on Planck-Scale Mass Dark Matter with Multiple-Scatter Signatures Using the DEAP-3600 Detector.

Physical review letters·2022
Same author

Pulse-shape discrimination against low-energy Ar-39 beta decays in liquid argon with 4.5 tonne-years of DEAP-3600 data.

The European physical journal. C, Particles and fields·2021
Same author

The year's new drugs and biologics 2020.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

The year's new drugs and biologics 2019.

Drugs of today (Barcelona, Spain : 1998)·2020
Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023
Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K

Cachexia.

A I Graul1, M Stringer2, L Sorbera2

  • 1Thomson Reuters, Barcelona, Spain. ann.graul@thomsonreuters.com.

Drugs of Today (Barcelona, Spain : 1998)
|November 25, 2016
PubMed
Summary
This summary is machine-generated.

Cachexia, a severe wasting syndrome, impacts patients with chronic illnesses. New drug candidates targeting its mechanisms offer hope for improved treatment strategies and patient outcomes.

Keywords:
CachexiaCannabinoidsMelanocortin receptor antagonistsMyostatin/activin pathwayβ-Adrenoceptor agonists

More Related Videos

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.7K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 11, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.3K
Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.7K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.8K

Area of Science:

  • Medical Science
  • Pathophysiology
  • Pharmacology

Background:

  • Cachexia is a complex, irreversible wasting syndrome linked to cancer and chronic diseases like heart failure, kidney disease, COPD, and AIDS.
  • Current treatments focus on anorexia and metabolic issues, but deeper understanding reveals new therapeutic avenues.
  • Muscle wasting is a key feature, driving the need for targeted interventions.

Purpose of the Study:

  • To review the pathophysiology, epidemiology, diagnosis, and treatment of cachexia.
  • To explore emerging drug candidates and therapeutic targets for cachexia.
  • To provide a comprehensive overview of cachexia management and research.

Main Methods:

  • Literature review of cachexia pathophysiology and epidemiology.
  • Analysis of current treatment strategies for anorexia and metabolic disturbances.
  • Survey of drug development pipelines, including hormone/cytokine receptor modulators, myostatin/activin antagonists, beta-adrenoceptor agonists, and cannabinoids.

Main Results:

  • Cachexia involves complex multiorgan and multifactorial mechanisms.
  • Several drug classes are in active development, targeting key pathways in cachexia.
  • Understanding muscle wasting mechanisms is crucial for novel therapeutic interventions.

Conclusions:

  • Cachexia requires multifaceted treatment approaches.
  • Emerging therapies hold promise for addressing the underlying causes of cachexia.
  • Continued research into therapeutic targets is essential for improving patient care.